Contrast-Enhanced whole-heart mr coronary angiography at 3.0 t using the intravascular contrast agent gadofosveset

Investigative Radiology

Volumn 44, Issue 7, 2009, Pages 369-374

  Prompona, Maria ^a,b   Cyran, Clemens ^a   Nikolaou, Konstantin ^a   Bauner, Kerstin ^a   Reiser, Maximilian ^a   Huber, Armin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b 145 61 Kifisia   (Greece)

Author keywords

3 Tesla; Contrast; Contrast enhanced; Coronary magnetic resonance angiography; Image quality

Indexed keywords

GADOFOSVESET;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EPICARDIUM; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; STEADY STATE;

EID: 67651065568     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181a40d1d     Document Type: Article

References (34)

1. Finn JP, Nael K, Deshpande V, et al. Cardiac MR imaging: state of the technology. Radiology. 2006;241:338-354.
2. Shea SM, Deshpande VS, Chung YC, et al. Three-dimensional true-FISP imaging of the coronary arteries: improved contrast with T2-preparation. J Magn Reson Imaging. 2002;15:597-602.
3. Spuentrup E, Bornert P, Botnar RM, et al. Navigator-gated free-breathing three-dimensional balanced fast field echo (TrueFISP) coronary magnetic resonance angiography. Invest Radiol. 2002;37:637-642.
4. Deshpande VS, Shea SM, Laub G, et al. 3D magnetization-prepared true- FISP: a new technique for imaging coronary arteries. Magn Reson Med. 2001;46:494-502.
5. Maintz D, Aepfelbacher FC, Kissinger KV, et al. Coronary MR angiography: comparison of quantitative and qualitative data from four techniques. AJR. 2004;182:515-521.
6. Maroules CD, McColl R, Khera A, et al. Assessment and reproducibility of aortic atherosclerosis magnetic resonance imaging: impact of 3-Tesla field strength and parallel imaging. Invest Radiol. 2008;43:656-662.
7. Wen H, Jaffer FA, Denison TJ, et al. The evaluation of dielectric resonators containing H2O or D2O as RF coils for high-field MR imaging and spectroscopy. J Magn Reson B. 1996;110:117-123.
8. Stuber M, Botnar RM, Fischer SE, et al. Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med. 2002;48:425-429.
9. Nezafat R, Stuber M, Ouwerkerk R, et al. B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T. Magn Reson Med. 2006;55:858-864.
10. Kaul MG, Stork A, Bansmann PM, et al. Evaluation of balanced steady-state free precession (TrueFISP) and K-space segmented gradient echo sequences for 3D coronary MR angiography with navigator gating at 3 Tesla. Rofo.2004;176: 1560-1565.
11. Sommer T, Hackenbroch M, Hofer U, et al. Coronary MR angiography at 3.0 T versus that at 1.5 T: initial results in patients suspected of having coronary artery disease. Radiology. 2005;234:718 -725.
12. Bi X, Li D. Coronary arteries at 3.0 T: contrast-enhanced magnetization- prepared three-dimensional breathhold MR angiography. J Magn Reson Imaging. 2005;21:133-139.
13. Li D, Carr JC, Shea SM, et al. Coronary arteries: magnetization-prepared contrast-enhanced three-dimensional volume-targeted breath-hold MR an- giography. Radiology. 2001;219:270-277.
14. Liu X, Bi X, Huang J, et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 T. Invest Radiol. 2008;43:663-668.
15. Kelle S, Thouet T, Tangcharoen T, et al. Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset). Med Sci Monit. 2007; 13:CR469 -CR474.
16. Bi X, Carr JC, Li D. Whole-heart coronary magnetic resonance angiography at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent. Magn Reson Med. 2007;58:1-7.
17. Zheng J, Bae KT, Woodard PK, et al. Efficacy of slow infusion of gadolinium contrast agent in three-dimensional MR coronary artery imaging. J Magn Reson Imaging. 1999;10:800-805.
18. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006;241:861-872.
19. Nassenstein K, Waltering KU, Kelle S, et al. Magnetic resonance coronary angiography with Vasovist: in-vivo T1 estimation to improve image quality of navigator and breath-hold techniques. Eur Radiol. 2008;18:103-109.
20. Weber OM, Martin AJ, Higgins CB. Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med. 2003; 50:1223-1228.
21. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology. 1998;207:529-538.
22. Frenzel T, Lengsfeld P, Schirmer H, et al. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol. 2008;43:817-828.
23. Bluemke DA, Stillman AE, Bis KG, et al. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology. 2001;219:114-122.
24. Lei T, Udupa JK, Saha PK, et al. 3D MRA visualization and artery-vein separation using blood-pool contrast agent MS-325. Acad Radiol. 2002; 9(suppl 1):S127-S133.
25. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33:1756-1824.
26. Schar M, Kozerke S, Fischer SE, et al. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med. 2004;51:799-806.
27. Deshpande VS, Shea SM, Li D. Artifact reductionintrue-FISP imaging ofthe coronary arteries by adjusting imaging frequency. Magn Reson Med. 2003; 49:803-809.
28. Bi X, Deshpande V, Simonetti O, et al. Three-dimensional breathhold SSFP coronary MRA: a comparison between 1.5T and 3.0T. J Magn Reson Imaging. 2005;22:206-212.
29. Goldfarb JW, Edelman RR. Coronary arteries: breath-hold, gadolinium- enhanced, three-dimensional MR angiography. Radiology. 1998;206:830-834.
30. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology. 2001;218:670-678.
31. Herborn CU, Barkhausen J, Paetsch I, et al. Coronary arteries: contrast- enhanced MR imaging with SH L 643A-experience in 12 volunteers. Radiology. 2003;229:217-223.
32. Port M, Corot M, Violas X, et al. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol. 2005;40:565-573.
33. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724.
34. Gupta A, Lee VS, Chung YC, et al. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology. 2004; 233:921-926.